Updated: Jan 7, 2009
Animal bites are not uncommon occurrences. However, victims who are treated in emergency centers represent only a small percentage of all bite victims. Although notification is mandatory in many states, an estimated 50% of all dog bites are not reported.
Most animal bites are dog bites (80-90%). Cat bites make up approximately 10%, and bites from miscellaneous animals and rodents also contribute to these figures.
Most animal bites occur on the extremities, but the head and neck region is also often affected. Animal bites to the face are most commonly made by dogs or cats. Of all dog bites, 9-36% occur to the head and neck region. The head and neck region is injured in 6-20% of persons who sustain cat bites. Children are injured more frequently in the head and neck region than adults.
Most bites occur in the summer months in the late afternoon. Additionally, most bites occur in the victim's home or in the home of a friend or relative. Often, the animal is known to the victim (eg, a pet).
Although the risk of infection exists in any bite situation and proper wound management is required, animal bites to the head and neck require special considerations. The intimate juxtaposition of vital structures and the cosmetic issues of the head and neck region warrant special care for animal bite wounds to these areas.
Animal bites account for 1% of the emergency department visits in the United States. Up to 4.5 million people are treated for animal bites each year.
In studies from England and Scotland, animal bite injuries account for 3% of emergency department visits. In Switzerland, up to 23,000 people are treated for animal bites and scratches annually.
Animal bites can lead to infection, and, if treated appropriately, patients can avoid this risk. Other complications include sepsis, osteomyelitis, septic arthritis, and even death. Fatalities are uncommon, but an average of 10-15 deaths occur following dog bites each year in the United States. Most of these fatalities are children who sustain bites to the head and neck region. Even a minor bite to a major vessel can lead to hemorrhage in a small child. Skull fractures resulting from dog bites have been reported.
Epidemiologic data have failed to demonstrate an association between race and bites.
In general, animal bites occur with equal incidence in men and women. However, dog bites occur more frequently in men and boys, while cat bites occur more frequently in women and girls.
Animal bites occur more frequently in adults. However, children have a higher percentage of head and neck bites. Additionally, bites in children are more likely to warrant medical attention.
The breed of the dog has been reported for some bites. Most bites (>50%) are inflicted by working dogs, which includes German shepherds, Doberman pinschers, collies, Great Danes, huskies, and mixed shepherd-type dogs. Sporting dogs, such as spaniels, retrievers, pointers, and setters, are implicated less frequently. Cats are not typically identified by breed.
Epidemiologic studies have shown that most dog and cat bites are not from stray animals. Rather, the animal is often the pet of the victim or an acquaintance of the victim. In many animal bites in children, the animal was inadvertently provoked by the child. Infant swings have been linked to dog attacks.[1 ]
Routine laboratory studies are not mandatory in the workup following an animal bite. However, with the risk of infection or sepsis, a complete blood cell count and cultures may provide useful information for treatment.
Imaging studies are not routinely performed, except for possible fractures. An imaging study may be helpful to identify the presence of a foreign body (eg, a tooth).
Injuries to the head and neck region have a lower risk of infection than injuries to the extremities. The risk of infection is increased with puncture wounds, treatment delay (6-12 h), and in patients older than 50 years. Likewise, patients who are immunocompromised are at increased risk.
The most common organisms are Staphylococcus species, Streptococcus species, Pasteurella multocida, and anaerobic organisms. No single drug of choice exists for empiric therapy (ie, no single drug targets all these organisms).
Therapy must be comprehensive and cover all likely pathogens in the context of this clinical setting.
Drug combination treats bacteria resistant to beta-lactam antibiotics.
In children >3 mo, base dosing protocol on amoxicillin content. Due to different amoxicillin/clavulanic acid ratios in 250-mg tab (250/125) vs 250-mg chewable tab (250/62.5), do not use 250-mg tab until child weighs >40 kg.
500 mg PO tid
Not established
Coadministration with warfarin or heparin increases risk of bleeding
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Adjust dose in renal impairment; give for a minimum of 10 d to eliminate organism and prevent sequelae (eg, endocarditis, rheumatic fever); following treatment, perform cultures to confirm eradication of streptococci
Inhibits biosynthesis of cell wall mucopeptide. Bactericidal against sensitive organisms when adequate concentrations are reached. Most effective during stage of active multiplication. Inadequate concentrations may produce only bacteriostatic effects.
500 mg PO tid
Not established
Probenecid may increase effectiveness by decreasing clearance; tetracyclines are bacteriostatic, causing a decrease in effectiveness of penicillins when administered concurrently
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Caution in renal impairment
These agents are used to induce active immunity against tetanus in selected patients.
Immunizing agent of choice for most adults and children > 7 y is tetanus and diphtheria toxoids. Necessary to administer booster doses to maintain tetanus immunity throughout life. Pregnant patients should receive only tetanus toxoid, not a diphtheria antigen–containing product.
In children and adults, may administer into deltoid or midlateral thigh muscles. In infants, preferred site of administration is the mid thigh laterally.
Suggested dosing
Primary immunization: 0.5 mL IM; give 2 injections 4-8 wk apart and a third dose 6-12 mo after second injection
Booster dose: 0.5 mL every 10 y
Administer as in adults
Patients receiving immunosuppressants, including corticosteroids or radiation therapy, may remain susceptible despite immunization due to poor immune response; cimetidine may enhance or augment delayed hypersensitivity responses to skin-test antigens; avoid concurrent use of medication with systemic chloramphenicol because it may impair amnestic response to tetanus toxoid; concurrent use of tetanus immune globulin may delay development of active immunity by several days (interaction is nevertheless clinically insignificant and does not preclude its concurrent use)
Documented hypersensitivity; a history of any type of neurological symptoms or signs following administration of this product; FDA recommends that elective tetanus immunization be deferred during any outbreak of poliomyelitis because tetanus toxoid injections are an important cause of provocative poliomyelitis
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Not for use in actual tetanus infections or for immediate prophylaxis of unimmunized individuals (use tetanus antitoxin, preferably human tetanus immune globulin, instead); diminished antibody response to active immunization may be observed in patients receiving immunosuppressive therapy; better to defer primary diphtheria immunization until immunosuppressive therapy is discontinued; routine immunization of symptomatic and asymptomatic HIV-infected persons is recommended
In the event of possible rabies exposure, human diploid vaccine can be administered.
Inactivated form of virus grown in primary cultures of chicken fibroblasts. Offers active immunity and, when used in combination with human rabies immune globulin and local wound treatment, protects postexposure patients of all age groups. Fourteen days after initiating immunization series, antirabies antibody titers reach levels well above minimal protective level of 0.5 IU/mL.
Vaccine must be injected IM and never SC, ID, or IV. In adults, inject into deltoid muscle area. In small children, administer into anterolateral zone of thigh.
Suggested dosing
Postexposure prophylaxis (previously unvaccinated patients): 20 IU/kg as soon as possible after exposure, and a total of 5 IM doses (do not inject ID) each 1 mL on day 0, 3, 7, 14, and 28
Previously immunized patients: 1 mL IM/ID on day 0 and 3
Administer as in adults
Corticosteroids, antimalarials, and other immunosuppressive agents may reduce protective efficacy; persons receiving immunosuppressive therapy should receive rabies immune globulin (3 doses/mL each) by the IM route
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Caution in documented hypersensitivity (may pretreat such patients with antihistamines); never inject rabies vaccine in gluteal area; epinephrine injection (1:1000), volume replacement, oxygen, and corticosteroids must be immediately available to counteract anaphylactic reactions that may occur
Chu AY, Ripple MG, Allan CH, et al. Fatal dog maulings associated with infant swings. J Forensic Sci. Mar 2006;51(2):403-6. [Medline].
Baxter DN. The deleterious effects of dogs on human health: dog-associated injuries. Community Med. Feb 1984;6(1):29-36. [Medline].
Galloway RE. Mammalian bites. J Emerg Med. Jul-Aug 1988;6(4):325-31. [Medline].
Goldstein EJ. Bite wounds and infection. Clin Infect Dis. Mar 1992;14(3):633-8. [Medline].
Goldstein EJ. Management of human and animal bite wounds. J Am Acad Dermatol. Dec 1989;21(6):1275-9. [Medline].
Kizer KW. Epidemiologic and clinical aspects of animal bite injuries. JACEP. Apr 1979;8(4):134-41. [Medline].
Kountakis SE, Chamblee SA, Maillard AA, et al. Animal bites to the head and neck. Ear Nose Throat J. Mar 1998;77(3):216-20. [Medline].
Marcy SM. Infections due to dog and cat bites. Pediatr Infect Dis. Sep-Oct 1982;1(5):351-6. [Medline].
Massari M, Masini L. Relationships among injuries treated in an emergency department that are caused by different kinds of animals: epidemiological features. Eur J Emerg Med. Jun 2006;13(3):160-4. [Medline].
Matter HC, Sentinella Arbeitsgemeinschaft. The epidemiology of bite and scratch injuries by vertebrate animals in Switzerland. Eur J Epidemiol. Jul 1998;14(5):483-90. [Medline].
Oberascher G, Muss N, Gruber W, et al. [Animal bite injuries in the head and neck area and their care]. HNO. Oct 1985;33(10):443-8. [Medline].
Pinckney LE, Kennedy LA. Fractures of the infant skull caused by animal bites. AJR Am J Roentgenol. Jul 1980;135(1):179-80. [Medline].
Sacks JJ, Kresnow M, Houston B. Dog bites: how big a problem?. Inj Prev. Mar 1996;2(1):52-4. [Medline].
Stucker FJ, Shaw GY, Boyd S, et al. Management of animal and human bites in the head and neck. Arch Otolaryngol Head Neck Surg. Jul 1990;116(7):789-93. [Medline].
Weiss HB, Friedman DI, Coben JH. Incidence of dog bite injuries treated in emergency departments. JAMA. Jan 7 1998;279(1):51-3. [Medline].
animal bites, animal bite, bite, dog bite, cat bite, mammalian bite, bite wound, bite infection, animal bite wound, animal attack, dog attack, cat attack, bite victim, rodent bite, rat bite, mouse bite, raccoon bite, animal bite injury, cat scratch fever, catscratch fever, cat-scratch fever
Suzanne K Doud Galli, MD, PhD, Consulting Staff, Cosmetic Facial Surgery, Private Practice
Suzanne K Doud Galli, MD, PhD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Rhinologic Society, and Triological Society
Disclosure: Nothing to disclose.
Philip J Miller, MD, FACS, Assistant Professor, Department of Otolaryngology, Division of Facial Plastic and Reconstructive Surgery, New York University School of Medicine
Philip J Miller, MD, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American College of Surgeons, American Medical Association, and Phi Beta Kappa
Disclosure: Nothing to disclose.
Clark A Rosen, MD, Director, University of Pittsburgh Voice Center; Associate Professor, Department of Otolaryngology and Communication Science and Disorders, University of Pittsburgh School of Medicine
Clark A Rosen, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, and Pennsylvania Medical Society
Disclosure: Bioform Medical Consulting fee Consulting
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.
Dominique Dorion, MD, MSc, FRCSC, Program Director and Division Chair, Professor of Surgery, Division of Otolaryngology, University of Sherbrooke, Canada
Disclosure: Nothing to disclose.
Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.
Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)